Cellular Biomedicine Group Company

CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.
Technology: CAR-T
Industry: Cell Therapy, Delisted
Headquarters: Palo Alto, California, United States
Founded Date: 2009-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 7
Total Funding: 203643001
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-09-28
Last Funding Type: Series A

Visit Website
Register and Claim Ownership